FDA 483 - EUROSIREL S.P.A - May 24, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of EUROSIREL S.P.A, an OTC Drug-Device Manufacturer in Cusago, Milan, revealed multiple deficiencies. Observations included inadequate component identification testing, lack of second-person verification for component additions, incomplete batch production records, and insufficient equipment logs. Additionally, the firm failed to exercise strict control over labeling operations, indicating significant issues in quality control and manufacturing processes.
ID · 42450ca4-26d3-490c-886b-0bf517bc6ffb